Comments

Armata Pharmaceuticals

ARMPAMEX
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$3.00
0.031.01%
At Close: -
$3.20
0.26.67%
After Hours: Jul 12, 5:01 PM EDT
15 minutes delayed
Armata Pharmaceuticals (ARMP) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$7.00
Lowest Price Target1
$7.00
Consensus Price Target1
$7.00

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Armata Pharmaceuticals (AMEX:ARMP) Stock, Analyst Ratings, Price Targets, Forecasts

Armata Pharmaceuticals Inc has a consensus price target of $7 based on the ratings of 1 analysts. The high is $7 issued by HC Wainwright & Co. on July 11, 2024. The low is $7 issued by HC Wainwright & Co. on July 11, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 11, 2024, May 8, 2024, and March 22, 2024, respectively. With an average price target of $7 between HC Wainwright & Co., there's an implied 118.75% upside for Armata Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Armata Pharmaceuticals

Buy NowGet Alert
07/11/2024Buy Now118.75%HC Wainwright & Co.
Joseph Pantginis
$7 → $7ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now118.75%HC Wainwright & Co.
Joseph Pantginis
 → $7ReiteratesBuy → BuyGet Alert
03/22/2024Buy Now118.75%HC Wainwright & Co.
Joseph Pantginis
$7 → $7MaintainsBuyGet Alert
08/14/2023Buy Now118.75%HC Wainwright & Co.
Joseph Pantginis
$7 → $7ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now118.75%HC Wainwright & Co.
Joseph Pantginis
 → $7ReiteratesBuy → BuyGet Alert
03/17/2023Buy Now118.75%HC Wainwright & Co.
Joseph Pantginis
 → $7Reiterates → BuyGet Alert
03/07/2023Buy Now118.75%HC Wainwright & Co.
Joseph Pantginis
 → $7Reiterates → BuyGet Alert

FAQ

Q

What is the target price for Armata Pharmaceuticals (ARMP) stock?

A

The latest price target for Armata Pharmaceuticals (AMEX:ARMP) was reported by HC Wainwright & Co. on July 11, 2024. The analyst firm set a price target for $7.00 expecting ARMP to rise to within 12 months (a possible 133.33% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Armata Pharmaceuticals (ARMP)?

A

The latest analyst rating for Armata Pharmaceuticals (AMEX:ARMP) was provided by HC Wainwright & Co., and Armata Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for Armata Pharmaceuticals (ARMP)?

A

There is no last upgrade for Armata Pharmaceuticals

Q

When was the last downgrade for Armata Pharmaceuticals (ARMP)?

A

There is no last downgrade for Armata Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Armata Pharmaceuticals (ARMP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Armata Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Armata Pharmaceuticals was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.

Q

Is the Analyst Rating Armata Pharmaceuticals (ARMP) correct?

A

While ratings are subjective and will change, the latest Armata Pharmaceuticals (ARMP) rating was a reiterated with a price target of $7.00 to $7.00. The current price Armata Pharmaceuticals (ARMP) is trading at is $3.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch